GHSI Guardion Health Science Net earnings per share (EPS TTM)

Guardion Health Sciences - graphic logo of issuer GHSI

Outsourcing production and logistics to external partners optimizes drug delivery, as reflected in the rolling unit profit metric on the GURU.Markets chart, where the value -4.63 indicates the profitability status. Simultaneously, Guardion Health Science (GHSI) is implementing ESG standards in raw material purification, and following the sale of Viactiv, the company is focusing on the liquidation of the legal entity and shareholder payouts.

GHSI Guardion Health Net earnings per share for the last four quarters (07/04/2022 - 10/19/2024)

Summary analytical data breakdowns for Guardion Health Sciences, Inc. (GHSI)

- share price and expert price forecast:
Stock Quotes Guardion Health Science|GHSI - Average Forecast Price
- market capitalization data:
Market Capitalization Guardion Health Sciences, Inc.|GHSI - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Guardion Health Sciences|GHSI - Book Valuation of Business|Market Capitalization to Book Value Ratio guardionhealth.com|GHSI - Company Balance Sheet Assets
- debt and liquidity details:
Total Debt to Equity Ratio Guardion Health Science|GHSI - Long-Term Debt to Capital|Short-Term Debt to Capital Guardion Health Sciences Inc.|GHSI - Company Aggregate Debts|Debt to Book Capitalization Ratio Guardion Health Sciences, Inc.|GHSI - Company Long-Term Loans and Borrowings|Company Short-Term Debts Guardion Health Sciences|Quick Ratio guardionhealth.com
- earnings and multiples data:
GHSI - Net Financial Result|Expected Profit Guardion Health Science|GHSI - Market Cap to Earnings|Future Price to Earnings Guardion Health Sciences|GHSI - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio Guardion Health Sciences, Inc.|GHSI - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Guardion Health Sciences|GHSI - Earnings per share for the trailing year|Quarterly EPS earnings growth guardionhealth.com|GHSI - Earnings per share growth rate in current year|Earnings growth forecast for next year Guardion Health Science
Analysis of all company metrics:GHSI - Guardion Health Science
Flagship merchandise of Guardion Health Sciences, Inc.

Investors are evaluating Guardion Health Science through the lens of sustained demand for vision protection products. Net income per share (TTM) measures real equity returns, stripped of market revaluations. By analyzing the distribution of TTM net income per share, one can identify hidden liquidity risks behind static figures. For the issuer, this metric reflects the efficiency of marketing expenditures when launching premium products. A stable trend confirms the fundamental viability of the business model.

Competing companies

ALC: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months bausch.com|GKOS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Apellis Pharmaceuticals, Inc. (APLS)|Earnings per share for the last twelve months Belite Bio, Inc|Ocular Pharma (OCUL) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) HROW|viridiantherapeutics.com (VRDN) - Net earnings per share for the trailing year|LENZ Therapeutics - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Oculis AG OCS|EyePoint Pharma - Net earnings per share (EPS TTM)|KOD - Net earnings per share (EPS TTM)|aldeyra.com (ALDX) - Earnings per share for the last twelve months|KALA BIO - Earnings per share for the trailing year|IRD (Opus Genetics, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months OKYO (OKYO Pharma Inc)|Net earnings per share (EPS TTM) ADVM|Net earnings per share for the last four quarters Outlook Therapeutics Corp|Earnings per share for the last twelve months Clearside Biomedical CLSD|NovaBay Pharmaceuticals Inc. (NBY) - Net earnings per one share for the last twelve months|KPRX - Earnings per share for the last twelve months|ALIM (Alimera Sciences) - Earnings per share for the last 12 months|EYEN (eyenovia.com) - Net earnings per share for the last 12 months|Ocuphire Corporation - Earnings per share for the trailing year|OPT (Opthea Limited) - Net earnings per share (EPS TTM)